On Thursday December 10, 2020, the Supreme Court of the United States (SCOTUS) issued a unanimous decision in the case Rutledge v. PCMA ruling in favor of the Petitioner, Leslie Rutledge, the Attorney General of Arkansas, and against the... Read More
Frier Levitt Partner, Todd Mizeski, Esq. has an article featured in the current issue of Drug Topics discussing the Rutledge v. Pharmaceutical Care Management Association case that recently went before the Supreme Court (SCOTUS). The SCOTUS’s... Read More
On October 6, 2020, oral argument was entertained by the Supreme Court of the United States (“SCOTUS”) in Rutledge v. Pharmaceutical Care Management Association (PCMA), the first case to reach the high court challenging a State’s ability to... Read More
In FTC v. Surescripts, the Federal Trade Commission (“FTC”) has sued Surescripts alleging illegal vertical & horizontal restraints to maintain monopolies over “e-prescribing” markets. The FTC alleges Surescripts’ imposition of... Read More
In May 2019, Oklahoma passed the Patient Right to Pharmacy Care Act ("Act"). The Act takes aim at unfair pharmacy benefit manager (“PBM”) practices by expanding network access for independent pharmacies, prohibiting PBMs from requiring patients... Read More
On October 7, 2019, the Supreme Court (SCOTUS) denied certiorari in the matter of Pharmerica Corporation v. U.S. ex rel. Silver, leaving on the books the Third Circuit decision which held that the False Claims Act's (FCA) public disclosure bar "is... Read More
One cannot move in legal circles without hearing at least some discussion of the SCOTUS' position on the administrative state. With a now-entrenched conservative majority and at least two or three of those justices expressing doggedly... Read More
